Welcome to Oxford Medical Diagnostics

Oxford Medical Diagnostics develops and supplies breath analysis technologies for rapid, accurate, and low-cost monitoring of diseases and metabolic functions.

The current focus of OMD’s work is the development of a breath test to indirectly measure blood ketones. This test is designed to assist type 1 diabetics with their condition and its complications, particularly diabetic ketoacidosis, the main cause of mortality in diabetics. It is envisaged that this will provide a completely non-invasive, more user-friendly and accurate test compared with the current standard blood ketone strips, which require blood samples from a painful finger stick.

Developed within Professor Gus Hancock’s research group at the University of Oxford, the Company’s major proprietary technology – Cavity Enhanced Absorption Spectroscopy – allows the measurement of acetone at sub-parts-per-million levels in breath. The technology allows for sensitivity far beyond the current industry standard. There is also significant potential to exploit breath acetone measurements in a separate device as a surrogate marker for blood glucose.

OMD has brought together a highly experienced management team to realise the significant potential of the CEAS technology platform. The Company maintains close links with the University of Oxford and academics around the world.

For more information about our products, technologies and services or to explore the potential for investment, partnership or collaboration, please click here.

Gas Analysis
Breath Diagnostics
OMD Company Overview